1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
AACR-Lobular Breast Cancer Alliance Invasive Lobular Carcinoma Innovation and Discovery Grants is a grant from the American Association for Cancer Research (AACR) and the Lobular Breast Cancer Alliance that funds innovative basic and clinical research on invasive lobular carcinoma (ILC), the second most common histological subtype of breast cancer.
The program seeks paradigm-shifting ideas to advance diagnostics, staging, therapeutics, and follow-up care for ILC patients, including rare subtypes such as pleomorphic and alveolar ILC, as well as dormancy and recurrence studies. Awards of $50,000 over one year are available. Eligible applicants are postdoctoral researchers or equivalent.
The application deadline is April 9, 2026, with a grant start date of July 1, 2026.
Get alerted about grants like this
Save a search for “American Association for Cancer Research (AACR) and Lobular Breast Cancer Alliance” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
AACR-Lobular Breast Cancer Alliance Invasive Lobular Carcinoma Innovation and Discovery Grants | Grants | AACR Select "Patients / Caregivers / Public" or "Researchers / Professionals" to filter your results. To further refine your search, toggle appropriate sections on or off.
Patient / Caregivers / Public Researchers / Professionals Information for Current Grantees Research Training and Fellowships Career Development Awards Independent Research Grants AACR-Lobular Breast Cancer Alliance Invasive Lobular Carcinoma Innovation and Discovery Grants Start of Grant Term July 1, 2026 Application Deadline April 9, 2026 1:00 PM Additional Information Additional details regarding this grant can be found in the Program Guidelines and Application Instructions.
Final determinations of eligibility will not be completed until the AACR is in receipt of the submitted application. Invasive lobular carcinoma (ILC), also known as lobular breast cancer, is the second most common histological subtype of breast cancer. ILC has a unique biology and a distinct clinical pattern of behavior and is a challenging disease entity in terms of diagnostics, staging, and therapeutic options.
There is a critical need to advance understanding of this disease and improve treatment and follow-up care options for patients living with ILC.
The AACR-Lobular Breast Cancer Alliance Invasive Lobular Carcinoma Innovation and Discovery Grants is a joint effort to stimulate and develop creative, paradigm-shifting ideas in ILC research to ultimately contribute to development of new treatment options that may not be funded through conventional channels. These grants are intended to support innovative research projects focused on invasive lobular carcinoma (ILC).
Applications addressing any aspect of basic or clinical research directly related to lobular breast cancer are eligible. Proposals investigating rare ILC subtypes-such as pleomorphic and alveolar ILC-as well as studies on dormancy and recurrence will receive priority consideration. Each grant provides $50,000 over one year for expenses related to the research project.
Grant funds may be used for direct research expenses attributable to the project, which may include supplemental salary support, equipment, research/laboratory supplies, and other research expenses. Up to 5% of grant funds may be used on indirect costs. Program Guidelines and Application Instructions are available for download.
Please read all eligibility criteria and instructions carefully before submitting an application. Research Project Criteria These grants are intended to support innovative research projects focused on invasive lobular carcinoma (ILC). Applications addressing any aspect of basic or clinical research directly related to lobular breast cancer are eligible.
Proposals investigating rare ILC subtypes-such as pleomorphic and alveolar ILC-as well as studies on dormancy and recurrence will receive priority consideration. Applicants must have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree or equivalent.
At the start of the grant term on July 1, 2026, applicants must: Be independent investigators and be affiliated with an academic, medical, or non-profit research institution. If eligibility is based on a future position, the position must be confirmed at the time of application and CANNOT be contingent upon receiving this grant.
If the future position is at a different institution than the applicant’s current institution, the applicant must contact AACR’s Research and Grants Administration Department (AACR’s RGA) at [email protected] before submitting their application for information on additional verification materials/signatures that may be required. Work at an academic, medical, or research institution anywhere in the world.
There are no citizenship or geographic requirements. However, by submitting an application for this grant, an applicant applying from an institution located in a country in which they are not a citizen or a permanent resident assures that the visa status will provide sufficient time to complete the project and grant term at the institution from which they applied.
AACR Membership Requirements Applicants must be Active AACR members in good standing (dues paid for the current year). Please be informed that no dues are required for members located in countries building cancer research capacities ( view list of eligible countries here ). Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR Active membership by the application deadline.
Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR membership by the application deadline. Nonmembers can apply for membership online . Please review the Membership Categories for the category that best fits your qualifications.
Nonmembers must obtain a statement of support from a nominator who is an Active AACR member in good standing (dues paid for the current year). Nonmembers requiring assistance with finding a nominator may email [email protected] and include your geographical location to receive a list of members in your area to contact for nominations. For more information check the membership FAQ .
Members can renew their membership through myAACR . You will need your logon (email address) and password to access the member portal. If you require assistance logging in, please submit a help form .
Lapsed members must be members in good standing by the application deadline and should contact the Membership Department at [email protected] for assistance. The AACR requires applicants to submit an online application by 1 p. m.
U.S. Eastern Time on Thursday, April 9, 2026, using the ProposalCentral website . Download Program Guidelines and Application Instructions online . block needs to be placed in the location where the link block will be displayed--> The Progression of Cancer Research Funding, Prestigious Research Grants Professional Development Opportunities
Based on current listing details, eligibility includes: Researchers (postdoctoral or equivalent) developing creative, paradigm-shifting ideas in invasive lobular carcinoma research. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates $50,000 over 1 year Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is April 9, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.